G. Dolisi and . Biotop,

M. Guérin, Quel est le moment optimal pour administrer les IPP? Pharmactuel, Disponible sur, vol.36, p.10, 2003.

, Prise en charge du reflux gastro-oesophagien sans oesophagite chez l'adulte, 2011.

E. Bursaux, Connaître les cyclooxygénases pour mieux contrôler les effets des antiinflammatoires non-stéroïdiens. médecine/sciences, vol.10, p.468, 1994.

, Prévention des lésions gastro-duodénales induites par les antiinflammatoires non stéroïdiens (AINS), 2009.

R. Iu--td and . Orphanet, Syndrome de Zollinger Ellison

H. Autorité-de-santé, Les inhibiteurs de la pompe à protons chez l'adulte, 2009.

D. A. Corley, A. Kubo, W. Zhao, and C. Quesenberry, Proton Pump Inhibitors and Histamine-2 Receptor Antagonists are Associated with Hip Fractures among At-Risk Patients, Gastroenterology. juill, vol.139, issue.1, pp.93-101, 2010.

Y. Yang, J. D. Lewis, S. Epstein, and D. C. Metz, Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA. 27 déc, vol.296, issue.24, pp.2947-53, 2006.

A. Niklasson, L. Lindström, M. Simrén, G. Lindberg, and E. Björnsson, Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebocontrolled trial, Am J Gastroenterol. juill, vol.105, issue.7, pp.1531-1538, 2010.

C. Reimer, B. Søndergaard, L. Hilsted, and P. Bytzer, Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy, Gastroenterology. juill, vol.137, issue.1, p.1, 2009.

J. Gau, Y. , Y. Chen, R. Kao, and T. , Uses of proton pump inhibitors and hypomagnesemia, Pharmacoepidemiol Drug Saf. mai, vol.21, issue.5, pp.553-562, 2012.

R. J. Valuck and J. M. Ruscin, A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults, J Clin Epidemiol. 1 avr, vol.57, issue.4, pp.422-430, 2004.

J. Michal, T. Henry, and C. Street, Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults, Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 1 sept, vol.73, issue.17, pp.126-132, 2016.

A. Linsky, K. Gupta, E. V. Lawler, J. R. Fonda, and J. A. Hermos, Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection, Arch Intern Med. 10 mai, vol.170, issue.9, pp.772-780, 2010.

J. Leonard, J. K. Marshall, and P. Moayyedi, Systematic review of the risk of enteric infection in patients taking acid suppression, Am J Gastroenterol. sept, vol.102, issue.9, pp.2047-56, 2007.

C. Giuliano, S. M. Wilhelm, and P. B. Kale-pradhan, Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis, Expert Rev Clin Pharmacol. mai, vol.5, issue.3, pp.337-381, 2012.

N. Geevasinga, P. L. Coleman, A. C. Webster, and S. D. Roger, Proton Pump Inhibitors and Acute Interstitial Nephritis, Clin Gastroenterol Hepatol. 1 mai, vol.4, issue.5, pp.597-604, 2006.

I. J. Simpson, M. R. Marshall, H. Pilmore, P. Manley, L. Williams et al., Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 cases, Nephrology, vol.11, issue.5, pp.381-386, 2006.

Y. Xie, B. Bowe, Y. Yan, H. Xian, T. Li et al., Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study, BMJ. 30 mai, vol.365, p.1580, 2019.

W. Gomm, V. Holt, K. Thomé, F. Broich, K. Maier et al., Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis, JAMA Neurol. avr, vol.73, issue.4, pp.410-416, 2016.

S. Hussain, A. Singh, S. Zameer, M. C. Jamali, H. Baxi et al., No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis, J Gastroenterol Hepatol. 23 juill, 2019.

S. La,

D. Sur,

H. Autorité-de-santé, Mettre en oeuvre la conciliation des traitements médicamenteux en établissement de santé, 2018.

A. E. Stuck, A. L. Siu, G. D. Wieland, J. Adams, and L. Z. Rubenstein, Comprehensive geriatric assessment: a meta-analysis of controlled trials, Lancet Lond Engl, vol.342, issue.8878, pp.1032-1038, 1993.

A. A. Jarchow-macdonald and A. A. Mangoni, Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board, Geriatr Gerontol Int, vol.13, issue.4, pp.1002-1011, 2013.

J. Thorel, C. Mccambridge, A. Piau, M. Secher, É. Magre et al.,

, Therapie. déc, vol.71, issue.6, pp.589-93, 2016.

H. Michelon, A. Delahaye, L. Fellous, B. Davido, A. Dinh et al., Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics?, Eur J Clin Pharmacol. 1 sept, vol.75, issue.9, pp.1327-1336, 2019.

M. Reid, A. Keniston, J. C. Heller, M. Miller, S. Medvedev et al., Inappropriate prescribing of proton pump inhibitors in hospitalized patients, J Hosp Med. juin, vol.7, issue.5, pp.421-426, 2012.

A. W. Bundeff and K. Zaiken, Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice, J Manag Care Pharm JMCP. mai, vol.19, issue.4, pp.325-358, 2013.

B. T. Batuwitage, J. Kingham, N. E. Morgan, and R. L. Bartlett, Inappropriate prescribing of proton pump inhibitors in primary care, Postgrad Med J. janv, vol.83, issue.975, pp.66-74, 2007.

P. Nguyen and R. Tamaz, Inappropriate Prescription of Proton Pump Inhibitors in a Community Setting, Can J Hosp Pharm. août, vol.71, issue.4, pp.267-71, 2018.

. Lassalle-m, . Dray-spira-r, and . Dumarcet-n, Utilisation des inhibiteurs de la pompe à protons (IPP): étude observationnelle à partir des données du SNDS, 2015.

P. Martin, R. Tamblyn, A. Benedetti, S. Ahmed, and C. Tannenbaum, Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults, JAMA, vol.320, issue.18, pp.1889-98, 2018.

C. Tannenbaum, Ai-je encore besoin de ce médicament ?, 2014.

, Réseau canadien pour la déprescription. Ai-je encore besoin de ce médicament?, 2014.

, Annexe 1 : Exemple de bilan de médicamenteux réalisé par l'EMG

, Annexe 3 : Recommandations de prise en charge du reflux gastro-oesophagien sans oesophagite chez l'adulte par l'Assurance maladie

, Annexe 5 : Fiche Omédit « Votre médecin vous a prescrit un médicament inhibiteur de la pompe à protons (IPP)

, Arrêter mon médicament inhibiteur de la pompe à protons (IPP), c'est possible ! Annexe 7 : Fiche Omédit « Inhibiteur de la pompe à protons (IPP) : s'assurer de la pertinence des prescriptions